NONTUBERCULOUS MYCOBACTERIA IN CHILDREN WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME

被引:48
作者
HOYT, L
OLESKE, J
HOLLAND, B
CONNOR, E
机构
[1] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT PEDIAT,185 S ORANGE AVE,NEWARK,NJ 07103
[2] CHILDRENS HOSP NEW JERSEY,DEPT PEDIAT,NEWARK,NJ
[3] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT PREVENT MED,NEWARK,NJ 07103
[4] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,NEWARK AIDS CLIN TRIALS UNIT,NEWARK,NJ 07103
关键词
NONTUBERCULOUS MYCOBACTERIA; MYCOBACTERIUM-AVIUM COMPLEX; PEDIATRIC HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OPPORTUNISTIC INFECTIONS;
D O I
10.1097/00006454-199205000-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among 139 children with acquired immunodeficiency syndrome at Children's Hospital of New Jersey, 20 had positive cultures for nontuberculous mycobacteria. Eighty-five percent had Mycobacterium avium complex isolated and 70% had definite evidence of disseminated disease. Ninety-three percent had CD4 lymphocyte counts < 100 cells/mm3 and 95% had met acquired immunodeficiency syndrome criteria before the time of first positive culture. Clinical findings included failure to gain weight, anorexia, fever, abdominal pain/tenderness and anemia. The median age at onset of symptoms was 46 months and the median time between onset of symptoms and positive culture was 9 months. Outcome for patients with positive cultures for nontuberculous mycobacteria was poor, with 75% of the children surviving for less-than-or-equal-to 10 months. Nontuberculous mycobacteria are increasingly important causes of morbidity and indirect mortality in human immunodeficiency-infected children. Children with severe immunodeficiency are at particular risk. In addition to M. avium complex, other species of nontuberculous mycobacteria may be involved.
引用
收藏
页码:354 / 360
页数:7
相关论文
共 55 条
[1]   EFFECT OF COMBINED THERAPY WITH ANSAMYCIN, CLOFAZIMINE, ETHAMBUTOL, AND ISONIAZID FOR MYCOBACTERIUM-AVIUM INFECTION IN PATIENTS WITH AIDS [J].
AGINS, BD ;
BERMAN, DS ;
SPICEHANDLER, D ;
ELSADR, W ;
SIMBERKOFF, MS ;
RAHAL, JJ .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (04) :784-787
[2]  
BARBARO DJ, 1989, REV INFECT DIS, V11, P625
[3]  
BENSON CA, 1991, ARCH INTERN MED, V151, P582, DOI 10.1001/archinte.151.3.582
[4]   TREATMENT OF DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION OF BEIGE MICE WITH LIPOSOME-ENCAPSULATED AMINOGLYCOSIDES [J].
BERMUDEZ, LE ;
YAUYOUNG, AO ;
LIN, JP ;
COGGER, J ;
YOUNG, LS .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (06) :1262-1268
[5]  
BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006
[6]   ACTIVITIES OF AMIKACIN, ROXITHROMYCIN, AND AZITHROMYCIN ALONE OR IN COMBINATION WITH TUMOR NECROSIS FACTOR AGAINST MYCOBACTERIUM-AVIUM COMPLEX [J].
BERMUDEZ, LEM ;
YOUNG, LS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1149-1153
[7]   MYCOBACTERIUM-AVIUM COMPLEX - INDUCED SEPTIC ARTHRITIS AND OSTEOMYELITIS IN A PATIENT WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BLUMENTHAL, DR ;
ZUCKER, JR ;
HAWKINS, CC .
ARTHRITIS AND RHEUMATISM, 1990, 33 (05) :757-758
[8]  
CARPENTER JL, 1991, ANN INTERN MED, V13, P789
[9]  
CHAISSON R E, 1991, American Review of Respiratory Disease, V143, pA278
[10]   MYCOBACTERIUM-GORDONAE IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
CHAN, J ;
MCKITRICK, JC ;
KLEIN, RS .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (03) :400-400